Entheon Biomedical Corp. (ENTBF)
OTCMKTS
· Delayed Price · Currency is USD
0.0900
0.00 (0.00%)
Jun 11, 2025, 4:00 PM EDT
Entheon Biomedical Market Cap
Entheon Biomedical has a market cap or net worth of $1.12 million as of June 13, 2025. Its market cap has increased by 0.14% in one year.
Market Cap
1.12M
Enterprise Value
1.02M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.09
Market Cap Chart
Since November 12, 2020, Entheon Biomedical's market cap has decreased from 18.81M to 1.12M, a decrease of -94.07%. That is a compound annual growth rate of -46.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 11, 2025 | 1.12M | -2.08% |
| Dec 30, 2024 | 1.14M | 154.54% |
| Dec 29, 2023 | 447.43K | -48.76% |
| Dec 30, 2022 | 873.18K | -94.25% |
| Dec 31, 2021 | 15.18M | -55.24% |
| Dec 31, 2020 | 33.90M | 80.26% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.59B |
| Veradigm | 747.25M |
| Elite Pharmaceuticals | 734.44M |
| Nika Pharmaceuticals | 708.22M |
| Tian'an Technology Group | 637.25M |
| CytoDyn | 443.91M |
| Glass House Brands | 388.80M |
| Northwest Biotherapeutics | 377.72M |